This issue of Immunology and Allergy Clinics, guest edited by Mariana Castells, is devoted to Drug Hypersensitivity and Desensitizations. Articles in this issue include: Principles and Practice of Drug Desensitization; Incidence and Prevalence of Drug Hypersensitivity; Drug-Induced Anaphylaxis; Penicillin and Beta Lactam Hypersensitivity; Platins Chemotherapy Hypersensitivity: Prevalence and Management; Monoclonal Antibodies Hypersensitivity: Prevalence and Management; Injectable Drugs and MoAbs Reactions and Management with Desensitization; Delayed Cutaneous Reactions to Antibiotics, Management with Desensitization; Management of Children with Hypersensitivity to Antibiotics and MoAbs; Taxenes Hypersensitivity and Management; Progesterone Autoimmune Dermatitis; Severe Delayed Drug Reaction: Role of Genetics and Viral Infections; andAspirin and NSAIDS Hypersensitivity and Management.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Foreword: Drug Hypersensitivity: Broadening Horizons
Preface: Drug Hypersensitivity and Desensitizations
Penicillin and Beta-Lactam Hypersensitivity
Platinum Chemotherapy Hypersensitivity: Prevalence and Management
Management of Hypersensitivity Reactions to Taxanes
Monoclonal Antibodies Hypersensitivity: Prevalence and Management
Management of Children with Hypersensitivity to Antibiotics and Monoclonal Antibodies
Aspirin and Nonsteroidal Antiinflammatory Drugs Hypersensitivity and Management
Delayed Cutaneous Hypersensitivity Reactions to Antibiotics: Management with Desensitization
Subcutaneous Injectable Drugs Hypersensitivity and Desensitization: Insulin and Monoclonal Antibodies
Progestogen Hypersensitivity: An Evidence-Based Approach to Diagnosis and Management in Clinical Practice
Severe Delayed Drug Reactions: Role of Genetics and Viral Infections